Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering

Documenti analoghi

• Myocardial superoxide and peroxynitrite as strong independent predictors of paroxysmal atrial fibrillation post-CABG
  di: Demosthenous, M, et al.
  Pubblicazione: (2011)
• MYOCARDIAL SUPEROXIDE AND PEROXYNITRITE GENERATION PREDICT POST-OPERATIVE CLINICAL OUTCOME IN PATIENTS UNDERGOING ELECTIVE CABG
  di: Antoniades, C, et al.
  Pubblicazione: (2011)
• Short-term preoperative treatment with atorvastatin improves myocardial redox state in patients undergoing elective CABG by affecting NADPH oxidase activity and NOS coupling
  di: Antoniades, C, et al.
  Pubblicazione: (2010)
• Atorvastatin Treatment for Three Days Before CABG Improves Myocardial Redox State, by Modifying NADPH-Oxidase Activity and NOS Coupling
  di: Demosthenous, M, et al.
  Pubblicazione: (2010)
• Systemic Lipid Peroxydation and Myocardial Superoxide/Peroxynitrite Anions as Predictors of Post-Operative Outcome in Cardiac Surgery
  di: Margaritis, M, et al.
  Pubblicazione: (2011)